Vialox, also known as Pentapeptide-3V, is a synthetic cosmetic peptide primarily associated with skin care and aesthetic research. It is best known for its potential to reduce the appearance of expression lines by influencing facial muscle contraction rather than by altering skin structure directly. Because of this mechanism, it is often compared conceptually to topical wrinkle-relaxing agents, though it is not a drug or injectable treatment.
Vialox is most commonly found in topical cosmetic formulations and is not approved as a pharmaceutical therapy.
What Pentapeptide-3V Is
Pentapeptide-3V is a short chain of five amino acids designed to interact with pathways involved in neuromuscular communication at the skin surface. It is structurally engineered to resemble peptides that influence how nerve signals trigger muscle contraction.
Unlike collagen peptides or growth factor–related compounds, Pentapeptide-3V does not aim to rebuild tissue or stimulate regeneration. Its role is functional and cosmetic, focusing on reducing visible muscle-driven skin movement.
How Vialox Works
Vialox is believed to work by modulating the release or activity of neurotransmitters involved in muscle contraction. By partially inhibiting the signaling that causes facial muscles to tighten, it may help soften repetitive expressions that lead to dynamic wrinkles, such as those on the forehead or around the eyes.
This mechanism is localized and surface-level. It does not paralyze muscles or permanently alter nerve function, and its effects are temporary and dependent on continued use.
Potential Areas of Interest
Vialox is commonly associated with cosmetic research related to:
Reduction in the appearance of expression lines
Smoothing of dynamic wrinkles
Support for relaxed facial appearance
Non-invasive aesthetic applications
Topical alternatives to more aggressive cosmetic procedures
Its appeal lies in the idea of muscle relaxation without injections or systemic effects.
Biochemical Characteristics
Vialox is a short-chain synthetic peptide composed of five amino acids arranged to replicate the bioactive region of a venom-derived curaremimetic peptide. The sequence confers selective binding affinity toward peripheral nicotinic acetylcholine receptors in experimental models. Structural studies describe its interaction as competitive and reversible under controlled laboratory conditions.
Research Applications
Vialox is utilized in research settings to investigate peripheral neuromuscular junction signaling and receptor–ligand interactions. Experimental use includes in vitro neuromuscular junction assays and in vivo animal models to evaluate selective inhibition of acetylcholine-mediated signal transmission at muscle endplates, without engagement of central neuronal receptor populations.
Pathway / Mechanistic Context
Vialox functions as a competitive antagonist of peripheral nicotinic acetylcholine receptors (nAChRs). By occupying the receptor binding site, the peptide inhibits acetylcholine-induced ion channel activation at the neuromuscular junction. This interaction prevents downstream depolarization events required for muscle fiber activation, allowing detailed study of synaptic transmission dynamics and receptor specificity in laboratory models.
Preclinical Research Summary
Preclinical investigations involving Vialox include animal models and in vitro receptor-binding assays assessing neuromuscular signal modulation. Reported findings describe transient, reversible inhibition of acetylcholine receptor activity and corresponding changes in muscle contractile signaling parameters. These studies are used to characterize structure–function relationships of venom-derived peptide analogs under controlled experimental conditions.
Form & Analytical Testing
Vialox is supplied as a synthetic research-grade peptide. Identity and purity are typically confirmed using analytical techniques such as high-performance liquid chromatography (HPLC) and mass spectrometry (MS). Handling and storage should follow standard laboratory protocols applicable to peptide-based research reagents.




Reviews
There are no reviews yet.